Entrada Therapeutics, Inc.

By person

16 insiders · 282 transactions

5.8×

Dipal Doshi holds 5.8 times base salary in stock. $3.69M of shares against $635.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Dipal Doshi last reported holding, valued at $7.13, the price Common Stock was last bought or sold at on the open market here, on 9 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Redmile Group, LLC entity

10% owner

$20.00M (1)

—

+$20.00M

1,954,420

5.02%

$13.94M

—

BAKER BROS. ADVISORS LP entity

10% owner

$2.59M (40)

—

+$2.59M

4,691,392

12.05%

$33.45M

+8.5%

MPM BioVentures 2014, L.P.

10% owner

$2.00M (1)

$4.52M (14)

−$2.52M

8,203,463

21.07%

$58.49M

+90.0%

MPM BIOVENTURES 2018, L.P.

10% owner

$2.00M (1)

$4.52M (14)

−$2.52M

8,203,463

21.07%

$58.49M

+90.0%

Foley Todd

Director

$2.00M (1)

—

+$2.00M

4,425,784

11.37%

$31.56M

—

WENTWORTH KORY JAMES

Chief Financial Officer

—

$1.91M (37) scheduled

−$1.91M

117,277

0.3012%

$836.19K

—

Sethuraman Natarajan

President, Research & Develop.

—

$1.90M (21) scheduled

−$1.90M

214,238

0.5502%

$1.53M

+64.1%

Dowden Nathan J

President & COO

—

$1.90M (31) scheduled

−$1.90M

196,060

0.5035%

$1.40M

+315.9%

Doshi Dipal

CEO

—

$1.39M (49)

−$1.39M

517,290

1.33%

$3.69M

+314.5%

KREHER NERISSA

Chief Medical Officer

—

$998.17K (24) scheduled

−$998.17K

40,037

0.1028%

$285.46K

—

5AM Ventures V, L.P. entity

10% owner

$5.00M (1)

$4.07M (13)

+$931.96K

3,877,094

9.96%

$27.64M

+1,071%

KIM PETER S

Director

$641.94K (11)

—

+$641.94K

104,330

0.2679%

$743.87K

+121.8%

PARMAR KUSH

Director

$5.00M (1)

$4.72M (14)

+$284.85K

2,691,337

6.91%

$19.19M

—

Crowley John F

Director

$48.58K (1)

—

+$48.58K

5,000

0.0128%

$35.65K

—

Zeiher Bernhardt G

Director

$29.32K (1)

—

+$29.32K

5,000

0.0128%

$35.65K

—

ROCHE HOLDING LTD entity

10% owner

—

2,813,525

7.23%

$20.06M

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Dowden Nathan J

4 May 2026

President & COO

Sold after exercise

15,000

$15.33

$229.95K

WENTWORTH KORY JAMES

2 Dec 2024

Chief Financial Officer

Sold after exercise

5,000

$20.00

$99.98K

WENTWORTH KORY JAMES

29 Nov 2024

Chief Financial Officer

Sold after exercise

1,000

$19.97

$19.97K

WENTWORTH KORY JAMES

11 Nov 2024

Chief Financial Officer

Sold after exercise

8,637

$19.98

$172.56K

Dowden Nathan J

16 Aug 2024

President & COO

Sold after exercise

502

$16.70

$8.38K

Dowden Nathan J

16 Aug 2024

President & COO

Sold after exercise

26,595

$16.26

$432.42K

WENTWORTH KORY JAMES

26 Dec 2023

Chief Financial Officer

Sold after exercise

$16.67

$1.57K

WENTWORTH KORY JAMES

22 Dec 2023

Chief Financial Officer

Sold after exercise

3,677

$16.48

$60.61K

WENTWORTH KORY JAMES

22 Dec 2023

Chief Financial Officer

Sold after exercise

6,529

$15.24

$99.51K

WENTWORTH KORY JAMES

21 Dec 2023

Chief Financial Officer

Sold after exercise

2,200

$15.07

$33.15K

KREHER NERISSA

4 Aug 2023

Chief Medical Officer

Sold after exercise

6,898

$14.14

$97.52K

KREHER NERISSA

3 Aug 2023

Chief Medical Officer

Sold after exercise

9,464

$14.74

$139.53K

KREHER NERISSA

2 Aug 2023

Chief Medical Officer

Sold after exercise

$16.82

$1.14K

KREHER NERISSA

2 Aug 2023

Chief Medical Officer

Sold after exercise

1,000

$16.01

$16.01K

KREHER NERISSA

2 Aug 2023

Chief Medical Officer

Sold after exercise

9,280

$15.09

$140.01K

WENTWORTH KORY JAMES

11 Jul 2023

Chief Financial Officer

Sold after exercise

3,884

$18.00

$69.90K

WENTWORTH KORY JAMES

10 Jul 2023

Chief Financial Officer

Sold after exercise

6,116

$17.98

$109.96K

WENTWORTH KORY JAMES

21 Jun 2023

Chief Financial Officer

Sold after exercise

8,907

$15.17

$135.13K

WENTWORTH KORY JAMES

21 Jun 2023

Chief Financial Officer

Sold after exercise

8,593

$14.84

$127.52K

WENTWORTH KORY JAMES

8 Dec 2022

Chief Financial Officer

Sold after exercise

4,550

$18.95

$86.24K

WENTWORTH KORY JAMES

5 Dec 2022

Chief Financial Officer

Sold after exercise

200

$18.05

$3.61K

WENTWORTH KORY JAMES

2 Dec 2022

Chief Financial Officer

Sold after exercise

2,910

$18.20

$52.95K

WENTWORTH KORY JAMES

16 Nov 2022

Chief Financial Officer

Sold after exercise

200

$18.10

$3.62K

KREHER NERISSA

26 Oct 2022

Chief Medical Officer

Sold after exercise

4,317

$22.01

$95.02K

KREHER NERISSA

26 Oct 2022

Chief Medical Officer

Sold after exercise

643

$21.21

$13.64K

KREHER NERISSA

25 Oct 2022

Chief Medical Officer

Sold after exercise

100

$22.13

$2.21K

KREHER NERISSA

25 Oct 2022

Chief Medical Officer

Sold after exercise

2,998

$21.42

$64.22K

KREHER NERISSA

25 Oct 2022

Chief Medical Officer

Sold after exercise

4,942

$20.53

$101.46K

KREHER NERISSA

28 Sep 2022

Chief Medical Officer

Sold after exercise

3,122

$15.25

$47.61K

KREHER NERISSA

27 Sep 2022

Chief Medical Officer

Sold after exercise

2,403

$15.31

$36.79K

KREHER NERISSA

26 Sep 2022

Chief Medical Officer

Sold after exercise

300

$16.33

$4.90K

KREHER NERISSA

26 Sep 2022

Chief Medical Officer

Sold after exercise

2,768

$15.22

$42.13K

KREHER NERISSA

23 Sep 2022

Chief Medical Officer

Sold after exercise

939

$15.09

$14.17K

KREHER NERISSA

21 Sep 2022

Chief Medical Officer

Sold after exercise

3,341

$15.08

$50.39K

KREHER NERISSA

15 Sep 2022

Chief Medical Officer

Sold after exercise

106

$15.01

$1.59K

KREHER NERISSA

9 Sep 2022

Chief Medical Officer

Sold after exercise

800

$15.07

$12.05K

KREHER NERISSA

8 Sep 2022

Chief Medical Officer

Sold after exercise

1,221

$15.13

$18.48K

WENTWORTH KORY JAMES

24 Aug 2022

Chief Financial Officer

Sold after exercise

301

$14.23

$4.28K

WENTWORTH KORY JAMES

24 Aug 2022

Chief Financial Officer

Sold after exercise

2,817

$13.52

$38.09K

WENTWORTH KORY JAMES

23 Aug 2022

Chief Financial Officer

Sold after exercise

2,909

$13.09

$38.08K

WENTWORTH KORY JAMES

22 Aug 2022

Chief Financial Officer

Sold after exercise

217

$13.00

$2.82K

WENTWORTH KORY JAMES

19 Aug 2022

Chief Financial Officer

Sold after exercise

8,529

$13.08

$111.53K

WENTWORTH KORY JAMES

18 Aug 2022

Chief Financial Officer

Sold after exercise

200

$13.00

$2.60K

WENTWORTH KORY JAMES

17 Aug 2022

Chief Financial Officer

Sold after exercise

200

$13.07

$2.61K

WENTWORTH KORY JAMES

16 Aug 2022

Chief Financial Officer

Sold after exercise

200

$13.00

$2.60K

Showing 250 of 282 transactions. The figures above use every one of them.

Entrada Therapeutics, Inc.

By person

Individual transactions

What was left out